Moleculin Biotech Inc. (NASDAQ: MBRX) Stock Information | RedChip

Moleculin Biotech Inc. (NASDAQ: MBRX) Listen to this Section


$2.42
+0.1850 ( +8.30% ) 76.9K

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Market Data


Open


$2.42

Previous close


$2.23

Volume


76.9K

Market cap


$6.25M

Day range


$1.48 - $2.44

52 week range


$1.48 - $15.75

Insider Ownership Transactions

Total Amount Purchased: 2,878.00 | $ 6,950.37

Date Type Amount Purchased Purchaser
2024-07-05 Sale -982.00 KLEMP WALTER V
2024-06-25 Sale -4329.00 Foster Jonathan P.
2024-06-25 Sale -8990.00 KLEMP WALTER V
2024-06-25 Sale -1766.00 PICKER DONALD H
2024-06-21 Sale -2712.00 Foster Jonathan P.
2024-06-21 Sale -1078.00 PICKER DONALD H
2024-06-21 Sale -3750.00 KLEMP WALTER V
2024-06-18 Sale -834.00 Foster Jonathan P.
2024-06-18 Sale -1667.00 KLEMP WALTER V
2023-12-27 Buy 28986.00 Foster Jonathan P.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Aug 14, 2024
10-q Quarterly Reports 54 Aug 13, 2024
8-k 8K-related 34 Aug 06, 2024
8-k 8K-related 16 Aug 05, 2024
8-k 8K-related 43 Aug 01, 2024
8-k 8K-related 18 Aug 01, 2024
8-k 8K-related 16 Jul 10, 2024
4 Insider transactions 1 Jul 05, 2024
4 Insider transactions 1 Jun 25, 2024
4 Insider transactions 1 Jun 25, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.